Results 201 to 210 of about 271,613 (400)

Disseminated sporotrichosis with osteoarticular involvement in a patient with acquired immunodeficiency syndrome: a case report. [PDF]

open access: yesRev Soc Bras Med Trop
Santos APFBD   +9 more
europepmc   +1 more source

Periodontitis History Shapes the Early Peri‐Implant Microbiome Formation: A Metagenomic Analysis

open access: yesJournal of Clinical Periodontology, EarlyView.
ABSTRACT Aim This study aims to investigate the early alterations in microbiome construction and succession around dental implants in both periodontally healthy individuals and patients with a history of periodontitis during the first month after implant–crown placement.
Miao Wang   +7 more
wiley   +1 more source

Rearrangements of the BCL-6 gene in acquired immunodeficiency syndrome- associated non-Hodgkin's lymphoma: association with diffuse large-cell subtype [PDF]

open access: bronze, 1994
Gianluca Gaïdano   +6 more
openalex   +1 more source

Giant anogenital tumor of Buschke-Löwenstein in a patient living with human immunodeficiency virus/acquired immunodeficiency syndrome: a case report. [PDF]

open access: yesJ Med Case Rep, 2022
Kowo M   +5 more
europepmc   +1 more source

PIK3R1 mutations in individuals with insulin resistance or growth retardation: Case series and in silico functional analysis

open access: yesJournal of Diabetes Investigation, EarlyView.
We present a report on SHORT syndrome caused by PIK3R1 mutations, including findings from in silico analysis. Our results demonstrate that these mutations impair the ability of p85α to interact with phosphopeptides. ABSTRACT Aims/Introduction Phosphatidylinositol 3‐kinase (PI3K) plays a key role in insulin signaling, and mutations in PIK3R1, which ...
Tomofumi Takayoshi   +15 more
wiley   +1 more source

European Guideline (EuroGuiDerm) on atopic eczema: Living update

open access: yesJournal of the European Academy of Dermatology and Venereology, EarlyView.
The updated guideline includes a new evidence‐based recommendation for the IL‐13 inhibitor lebrikizumab. In addition, the Janus kinase inhibitors baricitinib and abrocitinib, which were initially only approved for adult patients, are now also recommended for children from the age of 2 and adolescents from the age of 12, respectively.
A. Wollenberg   +31 more
wiley   +1 more source

Home - About - Disclaimer - Privacy